Northland Securities analyst Jason Wittes assigned a Buy rating to Alphatec Holdings (ATEC – Research Report) yesterday and set a price target of $26.00. The company’s shares closed last Tuesday at $14.27.
According to TipRanks.com, Wittes is a 4-star analyst with an average return of 14.2% and a 58.3% success rate. Wittes covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Globus Medical, and Stereotaxis.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Alphatec Holdings with a $21.25 average price target.
Alphatec Holdings’ market cap is currently $1.44B and has a P/E ratio of -13.30. The company has a Price to Book ratio of 20.45.
Based on the recent corporate insider activity of 56 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ATEC in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.